Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise benefits besides shedding pounds soon surfaced. One of those – that the medication changed drinking and smoking habits overnight – understandably piqued the interest